Mylan rolls out HIV treatment medicine in Canada
Mylan launched three generic medications to treat HIV in Canada.
The pharmaceutical company, which is based in the Netherlands but run out of its corporate offices in Canonsburg, said it had received Health Canada approval for these generic drugs:
emtricitabine/tenofovir disoproxil fumarate 200 mg/300 mg, a generic alternative to Truvada efavirenz/emtricitabin e/tenofovir disoproxil fumarate 600 mg, 200 mg, and 300 mg, a generic alternative to Atripla tenofovir disoproxil 300 mg, a generic alternative…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Paul J. Gough Source Type: news
More News: American Health | Atripla | Canada Health | Health Management | Netherlands Health | Truvada | Viread